OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 06/09/2023
Week ended 06/09/2023
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 06/09/2023
The Largest M&A Deal of the Week:
-
- On June 5, 2023, Schwazze (SHWZ: NEO)(SHWZ: OTCQX) announced that it had acquired assets of Succellus, LLC, under which it will manage Everest Apothecary Inc., a New Mexico licensed medical and recreational cannabis company.
- Transaction consideration of $38M was paid by $12.50M of cash, $17.5M of seller notes, and an $8M earn-out.
- Everest has 14 dispensaries, one cultivation facility, and one manufacturing plant.
- On June 5, 2023, Schwazze (SHWZ: NEO)(SHWZ: OTCQX) announced that it had acquired assets of Succellus, LLC, under which it will manage Everest Apothecary Inc., a New Mexico licensed medical and recreational cannabis company.
Week ended 06/09/2023
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.